Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)


11 Stocks Surging Higher From Donald Trump’s Surprise Victory

The world is more than surprised that Donald Trump has scored an upset victory over rival Hillary Clinton. Many brokerage firms and economists said that a Trump victory would be awful ...
Read Full Story »
counting money

Why Ariad Pharma Earnings Are So Great Despite a Loss

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) reported its third-quarter financial results before the markets opened on Monday. The stock saw a handy gain early on Monday even, though the company had a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Brocade, Facebook, First Solar, Fitbit, ONEOK Partners, Sunrun and More

Stocks were indicated higher on Thursday after the Brexit theme has now switched to a softer Brexit path. This is also the first day of serious gains this week. Investors ...
Read Full Story »
Female patient on gurney

Ariad Pharma Rises on FDA Decision

Shares of Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) saw a modest gain early Monday after the company announced a recent U.S. Food and Drug Administration (FDA) decision. Specifically, the FDA said that ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: Ariad, AT&T, Chesapeake Energy, Hain Celestial, Nike, Visa and More

Stocks were looking for direction on Tuesday despite a slew of Dow and S&P 500 earnings reports. Investors still seem willing to buy each pullback, even if there are high ...
Read Full Story »

Why Negative Analyst Views May Matter So Much on Ariad

Shares of Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) were down handily on Monday. The drop follows news that JPMorgan downgraded the stock to Underweight from Neutral. The firm also set a $7 price target. ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Ariad Pharma, Comcast, ConEd, Electronic Arts, Kinder Morgan, 3M, Time Warner and More

Stocks were indicated higher on Monday, on what is truly a "Merger Monday." Earnings season has gotten off to a decent start. Investors still appear to be willing to buy ...
Read Full Story »
white pills

Jefferies Biotech and Health Care Momentum Stocks to Buy With Big Upside Potential

One of the best market conditions for active traders is one in which price momentum underperforms and then kicks back in with a vengeance, and given what we have experienced since ...
Read Full Story »

7 Key FDA Decisions and Clinical Trial Results Coming in Q4

U.S. Food and Drug Administration (FDA) rulings and the results from clinical trials have proven time and again that they can make or break companies. The biotech and pharmaceutical companies ...
Read Full Story »
child with cancer

ASCO Could Make or Break These 7 Cancer Drug Trials

It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. ...
Read Full Story »

4 Major FDA Decisions Expected by June

Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount ...
Read Full Story »

Who Really Won in the PDL and Ariad Royalty Deal?

The solid performance of the healthcare sector over the past year has been enhanced by mergers and acquisitions, licensing, and other forms of deals in the sector. This most recent ...
Read Full Story »
Active investor

Why These 2 Biotech Stocks May Be Bought Out Soon

Big pharmaceutical and biotech companies seeking to grow company sales and revenues have two solid avenues. One is a consistent and growing pipeline full with good potential drugs in clinical ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More

Stocks were trying to post a recovery on Thursday morning on the heels of three days worth of energy-related selling. Despite a relatively harsh drop, investors have proven over and ...
Read Full Story »
ten bucks

Ten Analyst Stocks to Buy Under $10 for Big Upside

Earnings season is winding down and the markets remain choppy. Investors are wary, but they want upside and they keep hearing that this is now a stock picker's market. 24/7 ...
Read Full Story »